CD8A and metastatic melanoma: While CD74 typically acts as a chaperone for MHC molecules under normal conditions [82, 83], it gets targeted by MIF in metastatic melanoma [84], altering its immunogenic role and reducing the DCs’ ability to expand antitumor CD8 + T cells [17].